Timing is everything: new study aims to find the best window to treat dangerous blood clots in the lungs

NCT ID NCT07436702

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing 500 adults with severe pulmonary embolism (a dangerous blood clot in the lungs) to see if the timing of clot-busting treatments affects survival and complications. Researchers want to find the optimal time window to start treatment, similar to how heart attacks and strokes are treated. The goal is to improve outcomes by understanding when treatment is most effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IRCCS Policlinico San Matteo

    RECRUITING

    Pavia, Pavia, 27100, Italy

  • UO Unità di Cure Intensive Cardiologiche e Cardiologia 1, Ospedale Niguarda, Milano

    RECRUITING

    Milan, Milano, 20162, Italy

  • UO di Cardiologia 1, Azienda Ospedaliero Universitaria Pisana, Pisa, Italia

    RECRUITING

    Pisa, Pisa, 56126, Italy

  • UO di Cardiologia, Azienda Ospedaliera Ordine Mauriziano di Torino

    RECRUITING

    Torino, Torino, 10128, Italy

  • UO di Sezione di Medicina Interna e Cardiovascolare, Ospedale Santa Maria della Misericordia, Perugia, Italia

    RECRUITING

    Perugia, Perugia, 06129, Italy

  • UOC di Cardiologia, Ospedali Riuniti Padova Sud, Monselice, Italia

    RECRUITING

    Monselice, Padova, 35043, Italy

  • UOC di Cardiologia, Ospedali dell'Ovest Vicentino, Arzignano, IItalia

    RECRUITING

    Arzignano, Vicenza, 36071, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.